doxazosin has been researched along with Age-Related Macular Degeneration in 1 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y | 1 |
| Palczewska, G | 1 |
| Mustafi, D | 1 |
| Golczak, M | 1 |
| Dong, Z | 1 |
| Sawada, O | 1 |
| Maeda, T | 1 |
| Maeda, A | 1 |
| Palczewski, K | 1 |
1 other study available for doxazosin and Age-Related Macular Degeneration
| Article | Year |
|---|---|
Systems pharmacology identifies drug targets for Stargardt disease-associated retinal degeneration.
Topics: Adenine; Adenylyl Cyclase Inhibitors; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Alcoh | 2013 |